AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

va-Q-tec AG

Investor Presentation Mar 23, 2021

459_ip_2021-03-23_b19dd6bd-c929-4d6e-8191-8009b7be4b81.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

va-Q-tec AG FY 2020 Earnings Release Call

Dr. Joachim Kuhn CEO, Stefan Döhmen CFO

March 29th, 2021

  • Highlights and Business Update
  • Financial Performance FY 2020
  • Outlook 2021
  • Q&A

Dr. Joachim Kuhn (CEO) Stefan Döhmen (CFO)

va-Q-tec with dynamic growth in FY 2020

Good growth performance Revenue +12% to 72.1 Mio. EUR (FY 2019: 64.7 Mio. EUR)

Systems revenue up 30% YoY to 19.5 Mio. EUR

(FY 2019: 15.1 Mio. EUR)

EBITDA +27% to 12.2 Mio. EUR* (FY 2019: 9.7 Mio. EUR)

*adj. for F/X effects

Healthcare Business with 74% Revenue share (FY 2019: 69%)

3

Group revenues grew by 12%, Healthcare & Logistics with 74% Revenue share

Strong growth fuelled by Services and Systems

Cash Flow Summary: Continued strong operating CF performance

Comments

Operating CF before and after WC positive, clear upward trend

Accelerated investing CF, as a consequence of spike in demand (CoVid-19)

Positive free CF postponed due to ramp-up of investments

Solid equity ratio of 35%, no goodwill

From production to vaccination –

VQT involded in all major steps of global distribution campaing

Moderna CoVid-19 vaccine arrives at US bases in Japan

Comments Reliable, safe handling using special thermo-boxes and containers for the delivery of raw materials for the production of vaccines is already necessary during their manufacture

  • International shipment of large quantities of finished vaccines often at sub-zero temperatures between -20°C and -70°C
  • Information on storage between 2°C and 8°C often refers only to the "last mile", where the vaccine must be stored for a maximum of a few days
  • Strong ties with all major vaccine manufacturers
  • Exclusive contract with one major vaccine player

Strategic development of Thermal Energy Efficiency Business

va-Q-tec and Uponor: Energy-efficient and form-flexible pipe insulation

  • Ecoflex VIP reduces heat losses in local and district heating networks by up to 60% save space massively
  • A new level of energy efficiency local and district heating networks.

va-Q-tec and Hutchinson: A Game Changer for VIPs in mobility applications

  • Energy efficiency of modern mobility solutions can be massively increased by using VQT's VIPs
  • Optimized thermal management of e.g. passenger cabins and batteries leads to significant increase in range of modern e-vehicles

Thank you for your attention!

va-Q-tec AG

Alfred-Nobel-Straße 33 97080 Würzburg Tel.: +49 931 35942-1616 Fax: +49 931 35942-0 [email protected]

TICKER

Q&A

Symbol: VQT Bloomberg: VQT:GR Reuters: VQTG:DE ISIN: DE0006636681 WKN: 663668

14

14

In mEUR FY 2020 in % FY 2019 in % Difference in %
Revenue 72.106 100.0% 64.667 100.0% 11.0%
Change in inventory 0.978 -0.295 431.5%
Own work capitalized (primarily building of own container fleet) 6.379 3.947 61.6%
Other operating
income
4.669 4.498 +3.8%
Total income 84.132 72.817 15.5%
COGS -32.751 -28.993 13.0%
Gross profit 51.381 71% 43.824 68% 17.2%
Personnel expenses -26.111 -22.389 16.6%
Other operating expense -13.871 -11.762 17.9%
EBITDA 11.399 16% 9.673 15% 17.8%
Depreciation & amortization -12.299 -12.232 0.6%
EBIT -0.900 -1% -2.559 -4% 64.8%
Valuation and result from equity investments -0.647 1.703 -62.0%
Financial result 1.259 -1.063 18.4%
EBT -1.512 -2% -1.919 -3% 21.2%
Income taxes 0.077 -0.647 111.9%
Net income -1.435 -2% -2.566 -4% 44.1%

In mEUR 31.12.2020 31.12.2019 Difference in %
Cash & cash equivalents 17.134 7.490 128.8%
Trade receivables 6.532 6.666 -2.0%
Inventories 11.615 10.676 8.8%
Other current assets 2.479 2.180 13.7%
Total current assets 37.760 27.012 39.8%
Tangible fixed assets 69.636 68.879 1.1%
Intangible assets 2.955 2.233 32.3%
Other noncurrent assets 8.717 7.665 13.7%
Total noncurrent assets 81.308 78.777 3.2%
Total assets 119.068 105.789 12.6%
Short-term
financial liabilities
16.561 23.194 -28.6%
Other
short-term
liabilities
4.639 5.095 -8.9%
Long-term
financial liabilities
51.187 28.246 81.2%
Other long-term
liabilities
5.425 6.547 -17.1%
Total provisions and liabilities 77.812 63.082 23.4%
Total equity 41.256 42.707 -3.4%
Total liabilities and equity 119.068 105.789 12.6%

In mEUR FY 2020 FY 2019 Difference in %
Cash flow from operating activities before change in NWC 6.745 5.808 16.1%
Cash flow from operating activities after change in NWC 7.405 7.188 3.0%
Cash flow from investing activities -11.819 -8.942 -32.2%
Free cash flow -3.946 -1.558 -153.3%
Cash flow from financing activities 14.124 -2.972 575.2%
Effects of exchange rate changes -66 62 -206.5%
Net cash inflow/outflow 9.710 -4.726 305.5%
Cash and cash equivalents per 31.12.2019 7.490 12.154 -38.4%
Cash and cash equivalents per 31.12.2020 17.134 7.490 128.8%

Talk to a Data Expert

Have a question? We'll get back to you promptly.